The Association between Spermidine/Spermine N
SSAT
cancers development
mechanisms
polyamines
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 May 2022
25 May 2022
Historique:
received:
26
04
2022
revised:
13
05
2022
accepted:
24
05
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
Spermidine/spermine N
Identifiants
pubmed: 35682610
pii: ijms23115926
doi: 10.3390/ijms23115926
pmc: PMC9179984
pii:
doi:
Substances chimiques
Polyamines
0
Spermine
2FZ7Y3VOQX
Acetyltransferases
EC 2.3.1.-
Spermidine
U87FK77H25
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Ann N Y Acad Sci. 2000 Jun;910:121-37; discussion 137-9
pubmed: 10911910
Prostate Cancer Prostatic Dis. 2021 Jun;24(2):542-548
pubmed: 33408349
Hum Genet. 2002 Sep;111(3):235-41
pubmed: 12215835
Nat Rev Cancer. 2018 Nov;18(11):681-695
pubmed: 30181570
Mol Cancer Ther. 2007 Jan;6(1):128-37
pubmed: 17237273
Cancer Growth Metastasis. 2015 Aug 09;8(Suppl 1):17-27
pubmed: 26380554
Exp Hematol. 2014 Jul;42(7):574-80
pubmed: 24607957
J Biol Chem. 2018 Nov 30;293(48):18736-18745
pubmed: 30333229
BMC Cancer. 2010 Oct 14;10:555
pubmed: 20946629
Amino Acids. 2014 Mar;46(3):511-9
pubmed: 23771789
Biomol Ther (Seoul). 2013 Jan;21(1):1-9
pubmed: 24009852
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6806-E6812
pubmed: 27698118
Front Cell Dev Biol. 2021 Nov 16;9:789517
pubmed: 34869391
Oncol Rep. 2012 Apr;27(4):1227-32
pubmed: 22179681
Mol Cancer Ther. 2004 Jul;3(7):813-22
pubmed: 15252142
Future Sci OA. 2018 Dec 11;5(2):FSO365
pubmed: 30820345
Clin Cancer Res. 2000 Sep;6(9):3657-61
pubmed: 10999758
J Biol Chem. 1999 Jul 30;274(31):22095-101
pubmed: 10419538
Biochimie. 2012 Sep;94(9):1876-83
pubmed: 22579641
Cancer Res. 2010 Jun 1;70(11):4560-8
pubmed: 20460526
Carcinogenesis. 2002 Feb;23(2):359-64
pubmed: 11872645
Oncogene. 2019 Oct;38(41):6794-6800
pubmed: 31399646
J Biol Chem. 2018 Nov 30;293(48):18770-18778
pubmed: 30355737
Oncotarget. 2017 Jan 3;8(1):1092-1109
pubmed: 27901475
Cancer Chemother Pharmacol. 2011 Feb;67(2):401-14
pubmed: 20443003
Cancer Prev Res (Phila). 2008 Jun;1(1):32-8
pubmed: 18841250
Cancer Chemother Pharmacol. 2013 Dec;72(6):1305-14
pubmed: 24121453
Biochemistry. 2007 Jun 19;46(24):7187-95
pubmed: 17516632
J Biol Chem. 1981 Mar 10;256(5):2454-9
pubmed: 7007382
Cancer Chemother Pharmacol. 2004 Aug;54(2):122-6
pubmed: 15138709
Cancer Chemother Pharmacol. 2020 Jun;85(6):1089-1096
pubmed: 32447421
Am J Physiol Endocrinol Metab. 2008 Jun;294(6):E995-1010
pubmed: 18349109
Arch Gen Psychiatry. 2006 Jan;63(1):35-48
pubmed: 16389195
Clin Cancer Res. 2002 Mar;8(3):684-90
pubmed: 11895896
Biochem J. 2003 Aug 1;373(Pt 3):661-7
pubmed: 12803540
Am J Physiol Cell Physiol. 2007 Mar;292(3):C1204-15
pubmed: 17065202
Cancer Res. 2014 Dec 1;74(23):6925-34
pubmed: 25277523
J Biol Chem. 2005 Feb 4;280(5):3295-304
pubmed: 15546879
Prostate. 2015 Aug 1;75(11):1150-9
pubmed: 25893668
Int J Mol Sci. 2021 Apr 22;22(9):
pubmed: 33922247
Cancer Res. 2000 Jan 1;60(1):28-34
pubmed: 10646846
Oncol Rep. 2008 Nov;20(5):1229-35
pubmed: 18949426
Cancer Chemother Pharmacol. 2021 Jan;87(1):135-144
pubmed: 33215270
Future Sci OA. 2018 Sep 10;4(10):FSO345
pubmed: 30450232
Clin Cancer Res. 1999 May;5(5):945-51
pubmed: 10353725
J Biol Chem. 2003 Nov 28;278(48):47762-75
pubmed: 14506281
Future Sci OA. 2019 Jul 01;5(7):FSO400
pubmed: 31428447
Front Oncol. 2012 Nov 16;2:162
pubmed: 23181218
Front Pharmacol. 2020 Feb 28;10:1670
pubmed: 32256343
Int J Mol Sci. 2022 Jan 23;23(3):
pubmed: 35163181